YNP-1807 |
ALZAIN |
REWISCA |
CI-1008 |
PD-144723 |
LYRICA |
LYRICA CR |
LECAENT |
AXALID |
PREGABALIN |
LYRICA® |
(S)-PREGABALIN |
(S)-3-ISOBUTYL GABA |
(S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID |
NERVALIN® |
3-ISOBUTYL GABA |
PD 144723 |
S-(+)-3-ISOBUTYLGABA |
CI 1008 |
chembl:CHEMBL1059 |
drugbank:00230 |
chemidplus:148553-50-8 |
pubchem.compound:5486971 |
rxcui:187832 |
Drug Class | anticonvulsants |
Year of Approval | 2004 |
Drug Class | analgesics |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | analgesic,neuropathic pain,for treatment of restlegs legs syndrome |
inhibitor (inhibitory) |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
Trial Name | pregabalin,Lyrica |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
Direct Interaction | yes |
modulator |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
modulator |
Direct Interaction | yes |
Mechanism of Interaction | Voltage-gated calcium channel modulator |
PREGABALIN | Primary Drug Name |
Drug Class | analgesics |
Year of Approval | 2004 |
Drug Class | anticonvulsants |
Drug Indications | analgesic,neuropathic pain,for treatment of restlegs legs syndrome |
Drug Class | Small Molecule |
FDA Approval | approved |
D00WUF | TTD Drug ID |